Heifets L et al. |
Capreomycin is active against non-replicating M. tuberculosis. |
2005 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:15804353
|
Gould SW et al. |
The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta. |
2010 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:20663145
|
Sethi S et al. |
Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis. |
2005 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:15755326
|
Sankar MM et al. |
In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay. |
2008 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:18620572
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Akram FE et al. |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). |
2016 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:27530257
|
Bago J et al. |
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. |
2010 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:20398300
|
Zanetti S et al. |
"In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis. |
2006 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:17107610
|
Chen J et al. |
Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29562911
|
Seck A et al. |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. |
2013 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:23298145
|
Dohar J et al. |
Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis. |
2004 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:15287988
|
Jones ME et al. |
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). |
2004 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:15283864
|
Mohan S et al. |
Physician behaviour for antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies. |
2004 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:15196306
|
Bolland MJ et al. |
Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report. |
2008 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:18226256
|
Korkmaz S et al. |
Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. |
2012 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:22607576
|
Myers AL et al. |
Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains. |
2009 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:19951439
|
Chen J and Raymond K |
Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. |
2006 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:16480505
|
Roberts JC et al. |
Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report. |
2008 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:18284686
|
Ali SM et al. |
Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. |
2005 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:16371157
|
Ben Mansour K et al. |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. |
2010 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:20707901
|
Anand TD et al. |
Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. |
2012 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:22296671
|
Tsumoto C et al. |
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. |
2009 |
Ann. Hematol. |
pmid:19096845
|
Soler JA et al. |
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study. |
2009 |
Ann. Hematol. |
pmid:19159929
|
Kornacker M et al. |
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases. |
2002 |
Ann. Hematol. |
pmid:11907791
|
Kato H et al. |
Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide. |
2013 |
Ann. Hematol. |
pmid:23625297
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Huang HC et al. |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab. |
2013 |
Ann. Hematol. |
pmid:23242476
|
Kim H et al. |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. |
2015 |
Ann. Hematol. |
pmid:25501820
|
Kobayashi T et al. |
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma. |
2018 |
Ann. Hematol. |
pmid:29427183
|
Todo K et al. |
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female. |
2016 |
Ann. Hematol. |
pmid:26957356
|
Alpen B et al. |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). |
2001 |
Ann. Hematol. |
pmid:11757689
|
Tsutsumi Y et al. |
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. |
2005 |
Ann. Hematol. |
pmid:16078036
|
Souto Filho JTD et al. |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection. |
2017 |
Ann. Hematol. |
pmid:28315923
|
Musher DM |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7778830
|
van der Meer JT and Danner SA |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7778831
|
Patel AM et al. |
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. |
2013 |
Ann. Intern. Med. |
pmid:23778904
|
Steinman MA et al. |
Changing use of antibiotics in community-based outpatient practice, 1991-1999. |
2003 |
Ann. Intern. Med. |
pmid:12667022
|
Chaisson RE et al. |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. |
1994 |
Ann. Intern. Med. |
pmid:7978715
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Shafran SD et al. |
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy. |
2002 |
Ann. Intern. Med. |
pmid:12416943
|
Vaira D et al. |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. |
2007 |
Ann. Intern. Med. |
pmid:17438314
|
Singh N and Yu VL |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7632282
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
McMahon BJ et al. |
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. |
2003 |
Ann. Intern. Med. |
pmid:13679322
|
Sjölund M et al. |
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. |
2003 |
Ann. Intern. Med. |
pmid:13679325
|
|
Summaries for patients. Past antibiotic use affects resistance and outcomes of Helicobacter pylori infection. |
2003 |
Ann. Intern. Med. |
pmid:13679344
|
|
Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria. |
2003 |
Ann. Intern. Med. |
pmid:13679347
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
Seow J and Chew FT |
Risk factors for Helicobacter pylori resistance. |
2004 |
Ann. Intern. Med. |
pmid:15172911
|
Jafri NS et al. |
Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. |
2008 |
Ann. Intern. Med. |
pmid:18490667
|
Berk SL |
New macrolide antibiotics. |
1992 |
Ann. Intern. Med. |
pmid:1386966
|
Ohkusa T et al. |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. |
1998 |
Ann. Intern. Med. |
pmid:9841603
|
|
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics. |
2002 |
Ann. Intern. Med. |
pmid:11797613
|
De Francesco V et al. |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. |
2006 |
Ann. Intern. Med. |
pmid:16418408
|
Meyer JM et al. |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. |
2002 |
Ann. Intern. Med. |
pmid:11777360
|
Trivedi S et al. |
Clarithromycin and digoxin toxicity. |
1998 |
Ann. Intern. Med. |
pmid:9518419
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Ferreri AJ et al. |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. |
2015 |
Ann. Oncol. |
pmid:25935794
|
Di Raimondo F et al. |
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? |
2007 |
Ann. Oncol. |
pmid:17065587
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Mullin D et al. |
Mycobacterium chelonae infections involving the head and neck. |
2009 |
Ann. Otol. Rhinol. Laryngol. |
pmid:19894399
|
Callaghan R and Allen M |
Mycobacterium malmoense infection of the knee. |
2003 |
Ann. Rheum. Dis. |
pmid:14583565
|
Hiramatsu M et al. |
Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. |
2012 |
Ann. Thorac. Surg. |
pmid:22119119
|
Fan X et al. |
Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. |
2006 |
Ann. Thorac. Surg. |
pmid:16488691
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Kadir IS et al. |
Recurrent acute rheumatic fever: a forgotten diagnosis? |
2004 |
Ann. Thorac. Surg. |
pmid:15276555
|
Bossert T et al. |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections. |
2005 |
Ann. Thorac. Surg. |
pmid:16039241
|
Watanabe M et al. |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. |
2006 |
Ann. Thorac. Surg. |
pmid:16731124
|
Gintovt EA |
[Use of clarithromycin in the treatment of atopic dermatitis complicated by staphylococcal infection]. |
2004 |
Antibiot. Khimioter. |
pmid:15164520
|
Vasil'ev IuV and Zvenigorodskaia LA |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer]. |
2002 |
Antibiot. Khimioter. |
pmid:12365323
|
Iakovlev EA et al. |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever]. |
2011 |
Antibiot. Khimioter. |
pmid:22856156
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Evdokimova AG et al. |
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)]. |
2013 |
Antibiot. Khimioter. |
pmid:24640139
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Shcherbakov PL |
[Clarithromycin in eradication therapy of helicobacter infections in children]. |
2001 |
Antibiot. Khimioter. |
pmid:11871315
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Iutanova NS |
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia]. |
2004 |
Antibiot. Khimioter. |
pmid:15344392
|
Budanov SV and Vasil'ev AN |
[Clarithromycin: specific features of antimicrobial spectrum and clinical use]. |
2004 |
Antibiot. Khimioter. |
pmid:15285409
|
Guchev IA et al. |
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)]. |
2002 |
Antibiot. Khimioter. |
pmid:12619516
|
Aoki D et al. |
Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. |
|
Anticancer Res. |
pmid:15816530
|
Ohara T et al. |
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736403
|
Watanabe K et al. |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561829
|
Endo H et al. |
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11709323
|
Kalach N et al. |
Clarithromycin resistance and eradication of Helicobacter pylori in children. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408237
|
Osborne CS et al. |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19596876
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Furuie H et al. |
Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19933801
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Atkinson BA et al. |
Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8619588
|
Andini N and Nash KA |
Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16801446
|
Secka O et al. |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23263004
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Cohen Y et al. |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793882
|
Furney SK et al. |
Activities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793895
|
Renvoisé A et al. |
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26324275
|